Gulf International Bank (UK)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.4M Buy
95,951
+33,245
+53% +$4.66M 0.3% 58
2025
Q4
$7.7M Buy
62,706
+147
+0.2% +$17.9K 0.25% 75
2025
Q3
$6.94M Sell
62,559
-1,148
-2% -$130K 0.23% 83
2025
Q2
$7.06M Sell
63,707
-8,136
-11% -$866K 0.25% 73
2025
Q1
$8.05M Sell
71,843
-25,796
-26% -$2.66M 0.28% 69
2024
Q4
$9.02M Sell
97,639
-1,066
-1% -$96K 0.23% 82
2024
Q3
$8.28M Sell
98,705
-4,422
-4% -$337K 0.21% 96
2024
Q2
$7.08M Sell
103,127
-104
-0.1% -$6.94K 0.18% 112
2024
Q1
$7.56M Buy
103,231
+712
+0.7% +$54.8K 0.19% 104
2023
Q4
$8.3M Sell
102,519
-11,556
-10% -$899K 0.23% 93
2023
Q3
$8.55M Sell
114,075
-12,048
-10% -$927K 0.24% 86
2023
Q2
$9.72M Sell
126,123
-38,963
-24% -$3.11M 0.24% 86
2023
Q1
$13.7M Sell
165,086
-43,742
-21% -$3.62M 0.29% 78
2022
Q4
$17.9M Hold
208,828
0.32% 74
2022
Q3
$12.9M Sell
208,828
-10,399
-5% -$656K 0.24% 82
2022
Q2
$13.7M Buy
219,227
+4,127
+2% +$256K 0.24% 84
2022
Q1
$12.8M Hold
215,100
0.19% 101
2021
Q4
$15.6M Sell
215,100
-42,931
-17% -$2.96M 0.22% 92
2021
Q3
$18M Buy
258,031
+2,666
+1% +$187K 0.23% 91
2021
Q2
$17.6M Sell
255,365
-835
-0.3% -$55.8K 0.22% 94
2021
Q1
$16.6M Sell
256,200
-26,763
-9% -$1.73M 0.23% 94
2020
Q4
$16.5M Sell
282,963
-20,223
-7% -$1.22M 0.22% 95
2020
Q3
$19.2M Sell
303,186
-3,184
-1% -$221K 0.27% 74
2020
Q2
$23.6M Buy
306,370
+2,832
+0.9% +$217K 0.36% 60
2020
Q1
$22.7M Buy
303,538
+1,128
+0.4% +$77.9K 0.43% 53
2019
Q4
$19.6M Sell
302,410
-750
-0.2% -$48.8K 0.3% 69
2019
Q3
$19.2M Sell
303,160
-2,153
-0.7% -$141K 0.32% 67
2019
Q2
$20.6M Sell
305,313
-1,450
-0.5% -$95.4K 0.34% 62
2019
Q1
$19.9M Sell
306,763
-815
-0.3% -$54.2K 0.35% 62
2018
Q4
$19.2M Sell
307,578
-136,544
-31% -$9.54M 0.38% 60
2018
Q3
$34.3M Buy
444,122
+20,150
+5% +$1.52M 0.41% 56
2018
Q2
$30M Buy
423,972
+10,026
+2% +$708K 0.38% 58
2018
Q1
$31.2M Buy
413,946
+1,744
+0.4% +$139K 0.4% 53
2017
Q4
$29.5M Hold
412,202
0.38% 57
2017
Q3
$33.4M Sell
412,202
-300
-0.1% -$22.9K 0.45% 45
2017
Q2
$29.2M Buy
412,502
+420
+0.1% +$27.9K 0.41% 47
2017
Q1
$28M Buy
412,082
+5,100
+1% +$359K 0.41% 47
2016
Q4
$29.1M Buy
406,982
+300
+0.1% +$22.3K 0.45% 44
2016
Q3
$32.2M Sell
406,682
-4,418
-1% -$359K 0.52% 37
2016
Q2
$34.3M Sell
411,100
-23,857
-5% -$2.12M 0.58% 36
2016
Q1
$40M Sell
434,957
-1,660
-0.4% -$150K 0.68% 29
2015
Q4
$44.2M Buy
436,617
+10,350
+2% +$1.08M 0.77% 26
2015
Q3
$41.9M Sell
426,267
-8,280
-2% -$920K 0.79% 22
2015
Q2
$50.9M Buy
434,547
+1,044
+0.2% +$114K 0.89% 16
2015
Q1
$42.5M Buy
433,503
+12,301
+3% +$1.25M 0.76% 25
2014
Q4
$39.7M Sell
421,202
-1,108
-0.3% -$115K 0.7% 27
2014
Q3
$45M Buy
422,310
+5,051
+1% +$495K 0.83% 19
2014
Q2
$34.6M Buy
417,259
+910
+0.2% +$70.8K 0.64% 29
2014
Q1
$29.5M Buy
416,349
+1,117
+0.3% +$87.6K 0.58% 33
2013
Q4
$31.2M Buy
+415,232
New +$28.9M 0.62% 31

Other funds holding GILD

Gulf International Bank (UK)'s GILD Position: Q1 2026 in Review

Gulf International Bank (UK) increased its Gilead Sciences (GILD) stake by 53% in Q1 2026, buying an estimated $4.66M and bringing the position to 95,951 shares worth $13.4M. The position accounts for 0.3% of the portfolio, ranked #58.

Gulf International Bank (UK) first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $50.9M in Q2 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Gulf International Bank (UK) held 95,951 shares of Gilead Sciences worth $13.4M as of Q1 2026.
  • Gulf International Bank (UK) bought 33,245 Gilead Sciences shares in Q1 2026, an estimated $4.66M.
  • Gilead Sciences made up 0.3% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #58 holding.
  • Gulf International Bank (UK) first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Gulf International Bank (UK)'s Gilead Sciences position peaked at $50.9M in Q2 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.